Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
ZHONGZHIPHARM: INTERIM REPORT 2024
Sep 16 17:05
ZHONGZHIPHARM: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Aug 23 19:56
ZHONGZHIPHARM: NOTIFICATION OF BOARD MEETING
Aug 13 16:30
ZHONGZHIPHARM: PROFIT WARNING
Jul 12 16:41
Read more
No Data